Teradyne (TER) Q3 2026 (USD): Adj. EPS 2.29 (exp. 2.08), Revenue 1.306bln (exp. 1.265bln); Adj. net income 359.9mln (exp. 320.3mln)

• Adj. EPS 1.95-2.25 (exp. 2.07)
• Revenue 1.31bln (exp. 1.27bln).

A double beat on adjusted EPS and revenue, with next-quarter guidance straddling consensus at the top end and revenue guided above, fits the pattern in which semicap and test names trade primarily on the guide rather than the print. For Teradyne specifically, the transmission runs through its two end markets: semiconductor test, which is levered to AI and compute silicon complexity, and robotics, which has historically been the swing factor between a clean beat-and-raise and a qualified one. The tell in prints of this kind is the mix: strength concentrated in test with robotics soft has tended to draw a more muted reaction than broad-based beats, while the gross margin line determines whether revenue upside is flowing through at incremental margins. Watch the call for commentary on test intensity per device and order visibility, which is where management has typically signalled the durability of the cycle before it shows in the numbers. The peer read-across runs to other test and handling names and, more loosely, to the broader semicap complex. As a first reaction, the guide above consensus on revenue is the part that carries the signal; the EPS range midpoint near consensus leaves the quality of the beat to the margin detail.